FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3178300156> ?p ?o ?g. }

• W3178300156 endingPage "149" @default.
• W3178300156 startingPage "140" @default.
• W3178300156 abstract "Purpose: To elucidate the usefulness of Japanese cedar pollen (JCP)-specific antigen-specific immunoglobulin (IgG) 4 as a biomarker for predicting the efficacy of sublingual immunotherapy for cedar pollen-induced allergic rhinitis. Methods: We divided a total of 105 cases with Japanese cedar pollinosis into three groups: “SLIT Successful,” SLIT Unsatisfactory,” and “SCIT” groups. The SLIT group patients were treated with JCP Droplet (Torii Pharmaceutical Co. Ltd., Tokyo, Japan) for one year from 2015 and were divided into two groups, the SLIT Successful group or the SLIT Unsatisfactory group. The SLIT Successful group (n = 16) were subjects treated by SLIT only, who were able to experience control of their naso-ocular symptoms without the need for antiallergic rescue agents during the peak season of atmospheric pollen. The SLIT Unsatisfactory group (n = 76) comprised subjects treated with SLIT only, who did not respond successfully, and were administered with rescue agents to control their naso-ocular symptoms. The SCIT group had been treated with standardized JCP extract (Torii Pharmaceutical Co., Ltd., Tokyo, Japan) for three years from 2012, and were also able to experience control of their symptoms during the peak pollen season without the need for antiallergic rescue agents. We determined the serum level of JCP-specific immunoglobulin E (IgE), IgG, and IgG4 used in the 3gAllergy-specific IgE assay (3gAllergy). The serum levels of periostin and SCCA2 were measured using established ELISA procedures (clones SS18A and SS17B; Shino-Test, Japan) following the manufacturer’s instructions. We then made ROC curves for each group and assessed which index was best able to predict the efficacy of sublingual immunotherapy. Results: Serum JCP-specific IgE was significantly lower in the SCIT group than in the SLIT Successful group and the SLIT Unsatisfactory group (p < 0.05). Serum JCP-specific IgG was significantly higher in the SCIT group and the SLIT Successful group than in the SLIT Unsatisfactory group (p < 0.05). Serum JCP-specific IgG4 was also significantly higher in the SCIT group and the SLIT Successful group than in the SLIT Unsatisfactory group (p < 0.05). There was no significant difference among serum levels of periostin in the SCIT group, the SLIT Successful group, or the SLIT Unsatisfactory group. There was also no significant difference in SCCA2 among the three groups. In terms of ROC curves, a serum JCP-specific IgG4 value greater than 989.5 UA/mL showed the best sensitivity (93.3%) and specificity (94.7%) (p < 0.05) among other parameters. Conclusions: The serum JCP-specific IgG4 level is significantly correlated with the clinical efficacy of SLIT. Serum JCP-specific IgG4 cutoff levels greater than 989.5 UA/mL were correlated with an effective clinical response to SLIT, with a sensitivity of 93.3% and a specificity of 94.7%." @default.
• W3178300156 created "2021-07-19" @default.
• W3178300156 creator A5000625624 @default.
• W3178300156 creator A5004289973 @default.
• W3178300156 creator A5005313502 @default.
• W3178300156 creator A5012556565 @default.
• W3178300156 creator A5014718861 @default.
• W3178300156 creator A5032106411 @default.
• W3178300156 creator A5048837917 @default.
• W3178300156 creator A5051113472 @default.
• W3178300156 creator A5052933075 @default.
• W3178300156 creator A5065969832 @default.
• W3178300156 creator A5066881350 @default.
• W3178300156 creator A5077701644 @default.
• W3178300156 creator A5089998559 @default.
• W3178300156 date "2021-07-14" @default.
• W3178300156 modified "2023-09-26" @default.
• W3178300156 title "Serum Concentrations of Antigen-Specific IgG4 in Patients with Japanese Cedar Pollinosis" @default.
• W3178300156 cites W1577022278 @default.
• W3178300156 cites W1973688027 @default.
• W3178300156 cites W2005107727 @default.
• W3178300156 cites W2014513314 @default.
• W3178300156 cites W2044853402 @default.
• W3178300156 cites W2045336002 @default.
• W3178300156 cites W2046940214 @default.
• W3178300156 cites W2061178990 @default.
• W3178300156 cites W2090489195 @default.
• W3178300156 cites W2117441064 @default.
• W3178300156 cites W2176748133 @default.
• W3178300156 cites W2346088533 @default.
• W3178300156 cites W2519570590 @default.
• W3178300156 cites W2741667319 @default.
• W3178300156 cites W2753302620 @default.
• W3178300156 cites W2756263342 @default.
• W3178300156 cites W2771948477 @default.
• W3178300156 cites W2786823650 @default.
• W3178300156 cites W2795796044 @default.
• W3178300156 cites W2889001491 @default.
• W3178300156 cites W2983803366 @default.
• W3178300156 cites W3041393431 @default.
• W3178300156 cites W3112304041 @default.
• W3178300156 doi "https://doi.org/10.3390/allergies1030013" @default.
• W3178300156 hasPublicationYear "2021" @default.
• W3178300156 type Work @default.
• W3178300156 sameAs 3178300156 @default.
• W3178300156 citedByCount "0" @default.
• W3178300156 crossrefType "journal-article" @default.
• W3178300156 hasAuthorship W3178300156A5000625624 @default.
• W3178300156 hasAuthorship W3178300156A5004289973 @default.
• W3178300156 hasAuthorship W3178300156A5005313502 @default.
• W3178300156 hasAuthorship W3178300156A5012556565 @default.
• W3178300156 hasAuthorship W3178300156A5014718861 @default.
• W3178300156 hasAuthorship W3178300156A5032106411 @default.
• W3178300156 hasAuthorship W3178300156A5048837917 @default.
• W3178300156 hasAuthorship W3178300156A5051113472 @default.
• W3178300156 hasAuthorship W3178300156A5052933075 @default.
• W3178300156 hasAuthorship W3178300156A5065969832 @default.
• W3178300156 hasAuthorship W3178300156A5066881350 @default.
• W3178300156 hasAuthorship W3178300156A5077701644 @default.
• W3178300156 hasAuthorship W3178300156A5089998559 @default.
• W3178300156 hasBestOaLocation W31783001561 @default.
• W3178300156 hasConcept C118487528 @default.
• W3178300156 hasConcept C126322002 @default.
• W3178300156 hasConcept C141105273 @default.
• W3178300156 hasConcept C147483822 @default.
• W3178300156 hasConcept C159654299 @default.
• W3178300156 hasConcept C199215989 @default.
• W3178300156 hasConcept C203014093 @default.
• W3178300156 hasConcept C207480886 @default.
• W3178300156 hasConcept C2777037608 @default.
• W3178300156 hasConcept C2777701055 @default.
• W3178300156 hasConcept C2780510475 @default.
• W3178300156 hasConcept C2909583644 @default.
• W3178300156 hasConcept C54355233 @default.
• W3178300156 hasConcept C71924100 @default.
• W3178300156 hasConcept C86803240 @default.
• W3178300156 hasConcept C8891405 @default.
• W3178300156 hasConcept C90924648 @default.
• W3178300156 hasConceptScore W3178300156C118487528 @default.
• W3178300156 hasConceptScore W3178300156C126322002 @default.
• W3178300156 hasConceptScore W3178300156C141105273 @default.
• W3178300156 hasConceptScore W3178300156C147483822 @default.
• W3178300156 hasConceptScore W3178300156C159654299 @default.
• W3178300156 hasConceptScore W3178300156C199215989 @default.
• W3178300156 hasConceptScore W3178300156C203014093 @default.
• W3178300156 hasConceptScore W3178300156C207480886 @default.
• W3178300156 hasConceptScore W3178300156C2777037608 @default.
• W3178300156 hasConceptScore W3178300156C2777701055 @default.
• W3178300156 hasConceptScore W3178300156C2780510475 @default.
• W3178300156 hasConceptScore W3178300156C2909583644 @default.
• W3178300156 hasConceptScore W3178300156C54355233 @default.
• W3178300156 hasConceptScore W3178300156C71924100 @default.
• W3178300156 hasConceptScore W3178300156C86803240 @default.
• W3178300156 hasConceptScore W3178300156C8891405 @default.
• W3178300156 hasConceptScore W3178300156C90924648 @default.
• W3178300156 hasIssue "3" @default.
• W3178300156 hasLocation W31783001561 @default.
• W3178300156 hasLocation W31783001562 @default.

• next